4-Antibody AG
Human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology.
Launch date
Employees
Basel Canton of Basel-Stadt (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
CHF2.8m | Seed | ||
CHF23.0m | Series A | ||
$30.0m | Acquisition | ||
Total Funding | CAD32.3m |